D. Widman

发表

Neutralization mechanism of a highly potent antibody against Zika virus

R. Baric, Shuijun Zhang, V. Kostyuchenko, 2016, Nature Communications.

Congenital Zika Virus Infection as a Silent Pathology With Loss of Neurogenic Output in the Fetal Brain

C. Studholme, R. Hevner, R. Baric, 2018, Nature Medicine.

Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation

Pauline E. Chugh, M. Heise, S. Lemon, 2014, Nature Medicine.

The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy.

Xian Chen, Yanbao Yu, D. Widman, 2012, Immunity.

In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals

D. Widman, S. Tamir, S. Shacham, 2018, bioRxiv.

Bioassay for the measurement of type-I interferon activity.

D. Widman, 2013, Methods in molecular biology.

against Lethal West Nile Virus Responses in Old Mice Generates Protective Repeated In Vivo Stimulation of T and B Cell

P. Mason, D. Widman, J. Nikolich-Žugich, 2011 .

Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines

Bhumi P. Patel, R. Baric, D. Widman, 2019, The Journal of infectious diseases.

Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate

R. Baric, D. Widman, B. Yount, 2018, The Journal of infectious diseases.

Subcapsular sinus macrophages limit dissemination of West Nile virus particles after inoculation but are not essential for the development of West Nile virus-specific T cell responses.

Alison Johnson, P. Mason, D. Widman, 2014, Virology.

Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone

Vineet D. Menachery, R. Baric, D. Widman, 2017, mSphere.

Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection.

T. Ishikawa, R. Tesh, P. Mason, 2010, The American journal of tropical medicine and hygiene.

THU0241 LUPUS PROGRESSION IS PREVENTED BY TREATMENT WITH VERDINEXOR, AN INHIBITOR OF THE NUCLEAR EXPORT PROTEIN EXPORTIN-1, BY LIMITING GERMINAL CENTER FORMATION AND DEVELOPMENT OF AUTOREACTIVE ANTIBODY SECRETING CELLS

D. Widman, J. Rangel-Moreno, J. Anolik, 2019, Poster Presentations.

Analyses of mutations selected by passaging a chimeric flavivirus identify mutations that alter infectivity and reveal an interaction between the structural proteins and the nonstructural glycoprotein NS1.

P. Mason, D. Widman, R. Suzuki, 2011, Virology.

A Reverse Genetics Platform That Spans the Zika Virus Family Tree

R. Baric, M. Heise, D. Widman, 2017, mBio.

A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies

R. Baric, D. Widman, J. Crowe, 2015, mBio.

Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes

R. Baric, D. Widman, B. Yount, 2018, PLoS pathogens.

Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus

R. Baric, M. Heise, D. Widman, 2016, mBio.

Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses.

P. Mason, D. Widman, I. Frolov, 2008, Advances in virus research.

MyD 88-Dependent SHIP 1 Regulates Proinflammatory Signaling Pathways in Dendritic Cells after Monophosphoryl Lipid A Stimulation of TLR 4

P. Klenerman, E. Jaffee, L. Boon, 2011 .

Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes

R. Baric, E. Harris, D. Widman, 2017, mBio.

of from a Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes.

R. Baric, D. Widman, L. Katzelnick, 2017 .

Monitoring of responsiveness in dialysis-transplant patients by delayed cutaneous hypersensitivity tests.

D. Widman, G. M. Williams, S. Sterioff, 1978, Transplantation proceedings.

A global map of the Zika virus phosphoproteome reveals host-driven regulation of viral budding

Anna M. Schmoker, R. Baric, M. Heise, 2021, bioRxiv.

Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization

R. Baric, D. Widman, B. Yount, 2018, Cell reports.

Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4

R. Baric, D. Widman, W. Messer, 2017, Scientific Reports.

Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination

A. Sette, D. Widman, J. Crowe, 2016, Journal of Virology.

Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system.

T. Ishikawa, P. Mason, D. Widman, 2008, Vaccine.

Repeated In Vivo Stimulation of T and B Cell Responses in Old Mice Generates Protective Immunity against Lethal West Nile Virus Encephalitis

P. Mason, D. Widman, J. Nikolich-Žugich, 2011, The Journal of Immunology.

Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1

R. Baric, E. Harris, D. Widman, 2016, Journal of Virology.

Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene.

T. Ishikawa, P. Mason, D. Widman, 2011, Vaccine.

Dengue virus envelope protein domain I/II hinge: a key target for dengue virus vaccine design?

R. Baric, D. Widman, 2015, Expert review of vaccines.

Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1β Secretion: A Primary Human Monocyte Model

D. Widman, J. Crowe, J. Ting, 2015, PloS one.

Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling.

T. Ishikawa, P. Mason, D. Widman, 2012, Vaccine.

RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters.

T. Ishikawa, P. Mason, D. Widman, 2009, Vaccine.

Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection.

T. Ishikawa, R. Tesh, P. Mason, 2010, The American journal of tropical medicine and hygiene.

Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system.

T. Ishikawa, P. Mason, D. Widman, 2008, Vaccine.

Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis.

T. Ishikawa, E. Konishi, P. Mason, 2008, Vaccine.